prof. dr. B. (Bob) Wilffert

Head of Department PharmacoTherapy, -Epidemiology and -Economics

Research

Postal address:
A Deusinglaan1
Gebouw 3214, ruimte 0466
9713 AV
Groningen
Netherlands
Phone: +31 50 363 7576
  1. 2018
  2. 2017
  3. Osmanova, D., Boiko, A. S., Fedorenko, O. Y., Pozhidaev, I. V., Freidin, M. B., Kornetova, E. G., ... Loonen, A. J. M. (2017). Association of polymorphism in the dopamine receptors and transporter genes with hyperprolactinemia in patients with schizophrenia. European Neuropsychopharmacology, 27(Suppl. 4), 923-924.
  4. Geers, L. M., Pozhidaev, I. V., Ivanova, S. A., Freidin, M. B., Cohen, D., Boiko, A. S., ... Loonen, A. J. M. (2017). Association between P-glycoprotein polymorphisms and antipsychotic drug-induced hyperprolactinemia. European Neuropsychopharmacology, 27(Supplement 4), S956. https://doi.org/10.1016/S0924-977X(17)31689-9
  5. Pozhidaev, I., Alifirova, V. M., Freidin, M. B., Zhukova, I. A., Fedorenko, O. Y., Osmanova, D. Z., ... Loonen, A. J. M. (2017). Dopamine receptors genes polymorphisms in Parkinson patients with levodopa-induced dyskinesia. European Neuropsychopharmacology, 27(Supplement 4), S590. https://doi.org/10.1016/S0924-977X(17)31129-X
  6. Ivanova, S. A., Alifirova, V. M., Freidin, M. B., Pozhidaev, I. V., Fedorenko, O. Y., Bokhan, N. A., ... Loonen, A. J. M. (2017). Predictive genetic model for levodopa-induced dyskinesia in patients with Parkinson's disease. European Neuropsychopharmacology, 27(Supplement 4), S1039-S1040. https://doi.org/10.1016/S0924-977X(17)31817-5
  7. Geers, L. M., Pozhidaev, I. V., Ivanova, S. A., Freidin, M. B., Cohen, D., Boiko, A. S., ... Loonen, A. J. M. (2017). Association between P-glycoprotein polymorphisms and antipsychotic drug-induced hyperprolactinemia. European Neuropsychopharmacology, 27, S956-S956.
  8. Pozhidaev, I., Alifirova, V. M., Freidin, M. B., Zhukova, I. A., Fedorenko, O. Y., Osmanova, D. Z., ... Loonen, A. J. M. (2017). Dopamine receptors genes polymorphisms in Parkinson patients with levodopa-induced dyskinesia. European Neuropsychopharmacology, 27, S590-S590.
  9. Nuntamool, N., Ngamsamut, N., Vanwong, N., Puangpetch, A., Chamnanphon, M., Hongkaew, Y., ... Sukasem, C. (2017). Pharmacogenomics and Efficacy of Risperidone Long-Term Treatment in Thai Autistic Children and Adolescents. Basic & clinical pharmacology & toxicology, 121(4), 316-324. https://doi.org/10.1111/bcpt.12803
  10. Ivanova, S. A., Alifirova, V. M., Freidin, M. B., Pozhidaev, I. V., Fedorenko, O. Y., Bokhan, N. A., ... Loonen, A. J. M. (2017). Predictive genetic model for levodopa-induced dyskinesia in patients with Parkinson's disease. European Neuropsychopharmacology, 27, S1039-S1040.
  11. Ivanova (Svetlana A. Ivanova), S. A., Osmanova, D., Boiko, A., Pozhidaev, I., Fedorenko, O., Kornetova, E., ... Loonen, A. (2017). Association between prolactin gene polymorphism (-1149 G/T) and hyperprolactinemia in anti-psychotic treated patients with schizophrenia. European Psychiatry, 41, S267-S267. https://doi.org/10.1016/j.eurpsy.2017.02.087
  12. Boiko, A. S., Losenkov, I. S., Levchuk, L. A., Simutkin, G. G., Bokhan, N. A., Bosker, F. J., ... Ivanova (Svetlana Ivanova), S. A. (2017). Biomarkers of depressive disorders: A multiplex analysis of blood serum. European Psychiatry, 41, S524-S524. https://doi.org/10.1016/j.eurpsy.2017.01.699
  13. Ivanova, S. A., Osmanova, D. Z., Boiko, A. S., Pozhidaev, I. V., Freidin, M. B., Fedorenko, O. Y., ... Loonen, A. J. M. (2017). Prolactin gene polymorphism (-1149 G/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics. Schizophrenia Research, 182, 110-114. https://doi.org/10.1016/j.schres.2016.10.029
  14. Geers, L., Pozhidaev, I. V., Ivanova, S. A., Freidin, M. B., Cohen, D., Boiko, A. S., ... Loonen, A. (2017). Association between P-glycoprotein polymorphisms and antipsychotic drug-induced hyperprolactinemia. Abstract from 30th ECNP Congress - Paris 2017, .
  15. Osmanova, D. Z., Boiko, A. S., Fedorenko, O. Y., Pozhidaev, I. V., Freidin, M. B., Kornetova, E. G., ... Loonen, A. (2017). Association of polymorphism in the dopamine receptors and transporter genes with hyperprolactinemia in patients with schizophrenia. Poster session presented at 30th ECNP Congress - Paris 2017, .
  16. Pozhidaev, I. V., Alifirova, V. M., Freidin, M. B., Zhukova, I. A., Fedorenko, O. Y., Osmanova, D. Z., ... Loonen, A. (2017). Dopamine receptors genes polymorphisms in Parkinson patients with levodopa-induced dyskinesia. Abstract from 30th ECNP Congress - Paris 2017, .
  17. 2016
  18. Hummels, H., Bertholee, D., van der Meer, D., Smit, J. P., Wilffert, B., & ter Horst, P. (2016). The quality of lactation studies including antipsychotics. European Journal of Clinical Pharmacology, 72(12), 1417-1425. https://doi.org/10.1007/s00228-016-2121-2
  19. Ivanova, S. A., Alifirova, V. M., Pozhidaev, I. V., Fedorenko, O. Y., Osmanova, D. Z., Tiguntsev, V. V., ... Loonen, A. J. M. (2016). CYP2D6 and catechol-O-methyltransferase gene polymorphisms in Parkinson patients with levodopa-induced dyskinesias. European Neuropsychopharmacology, 26, S656-S657.
  20. Osmanova, D. Z., Boiko, A. S., Fedorenko, O. Y., Pozhidaev, I. V., Freidin, M. B., Kornetova, E. G., ... Loonen, A. J. M. (2016). Gene polymorphism of serotonin receptors and drug-induced hyperprolactinemia in schizophrenic patients. European Neuropsychopharmacology, 26(Supplement 2), S515-S516. https://doi.org/10.1016/S0924-977X(16)31542-5
  21. 2015
  22. Ivanova, S. A., Fedorenko, O. Y., Freidin, M. B., Alifirova, V. M., Zhukova, N. G., Zhukova, I. A., ... Loonen, A. J. M. (2015). Dissimilar mechanistic background of peripheral and orofacial hyperkinesia in patients with Parkinson’s disease and levodopa-induced dyskinesia. Physiology and Pharmacology, 19(4), 216-221.
  23. Ivanova, S. A., Fedorenko, O. Y., Freidin, M. B., Alifirova, V. M., Zhukova, N. G., Zhukova, I. A., ... Loonen, A. J. M. (2015). Dissimilar mechanistic background of peripheral and orofacial hyperkinesia in patients with Parkinson's disease and levodopa-induced dyskinesia. Physiology and Pharmacology, 19(4), 216-221.

ID: 218810